Market Size of North America Continuous Glucose Monitoring Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 7.38 Billion |
| Market Size (2029) | USD 17.61 Billion |
| CAGR (2024 - 2029) | 19.01 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America CGM Market Analysis
The North America Continuous Glucose Monitoring Market size is estimated at USD 7.38 billion in 2024, and is expected to reach USD 17.61 billion by 2029, growing at a CAGR of 19.01% during the forecast period (2024-2029).
The continuous glucose monitoring (CGM) devices market in North America is experiencing significant growth due to the rising number of individuals with diabetes. This has created a demand for advanced technologies that can provide real-time monitoring of blood glucose levels, ultimately improving diabetes management and reducing the risk of complications.
CGM devices have become increasingly popular among individuals with diabetes in North America because of their ability to offer continuous, accurate, and real-time data on blood sugar levels. Unlike traditional blood glucose meters that require frequent fingerstick tests, CGM systems provide continuous monitoring, allowing users to track their glucose levels continuously and receive alerts for high or low blood sugar levels.
Furthermore, the convenience and user-friendly nature of CGM devices has contributed to their growing adoption among diabetes patients in North America. These devices offer valuable insights into how various factors, such as diet, exercise, medication, and lifestyle choices, impact blood sugar levels. This empowers individuals to make informed decisions regarding their diabetes management.
Moreover, advancements in CGM technology, including improved accuracy, smaller and more comfortable sensors, and integration with insulin pumps and mobile apps, have further propelled the growth of the CGM devices market in North America. These innovations have made CGM systems more accessible and appealing to a wider range of individuals with diabetes who are seeking effective ways to manage their condition.
The rising number of individuals with diabetes in North America, influenced by sedentary lifestyles, unhealthy eating patterns, and genetic predispositions, is fueling the need for continuous glucose monitoring devices. As a result, there is a growing demand for manufacturers to create and advance new CGM technologies that can effectively improve diabetes management and enhance the overall quality of life for people living with diabetes in the region.
Owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.
North America CGM Industry Segmentation
Continuous glucose monitoring is a wearable tool that makes it easier for people with diabetes to track their blood sugar levels over time and measures their glucose levels 24 hours a day while wearing the device. The North America Continuous Glucose Monitoring Market is segmented into Components and Geography. The report offers the value (in USD) and volume (in Units) for the above segments.
| Component | |
| Sensors | |
| Durables |
| Geography | |
| United States | |
| Canada | |
| Rest of North America |
North America Continuous Glucose Monitoring Market Size Summary
The North America Continuous Glucose Monitoring (CGM) market is experiencing robust expansion, driven by the increasing prevalence of diabetes and the demand for advanced monitoring technologies. CGM devices offer continuous, accurate, and real-time data on blood glucose levels, significantly enhancing diabetes management and reducing complications. These devices are gaining popularity due to their convenience and user-friendly nature, providing insights into how various factors affect blood sugar levels. Technological advancements, such as improved accuracy, smaller sensors, and integration with insulin pumps and mobile apps, have further fueled market growth. The rising number of individuals with diabetes, influenced by lifestyle and genetic factors, is prompting manufacturers to innovate and develop new CGM technologies to improve diabetes management and quality of life.
The market is dominated by major players like Dexcom, Medtronic, Abbott, and Senseonics, ensuring a competitive landscape that encourages technological innovation. The United States holds a significant share of the market, with a large population living with diabetes or prediabetes. Despite the high costs and varying adoption rates among different diabetes types, the benefits of CGMs are becoming increasingly recognized, with evidence supporting their use for insulin-treated patients. Recent FDA approvals for next-generation CGM products and their integration with automated insulin delivery systems highlight the ongoing advancements in the field. These developments are expected to drive further growth in the North American CGM market over the forecast period.
North America Continuous Glucose Monitoring Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Component
-
2.1.1 Sensors
-
2.1.2 Durables
-
-
2.2 Geography
-
2.2.1 United States
-
2.2.2 Canada
-
2.2.3 Rest of North America
-
-
North America Continuous Glucose Monitoring Market Size FAQs
How big is the North America Continuous Glucose Monitoring Market?
The North America Continuous Glucose Monitoring Market size is expected to reach USD 7.38 billion in 2024 and grow at a CAGR of 19.01% to reach USD 17.61 billion by 2029.
What is the current North America Continuous Glucose Monitoring Market size?
In 2024, the North America Continuous Glucose Monitoring Market size is expected to reach USD 7.38 billion.
